ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells

Background: Oxaliplatin (OXA) chemotherapy is widely used in the clinical treatment of colon cancer. However, chemo-resistance is still a barrier to effective chemotherapy in cases of colon cancer. Accumulated evidence suggests that the epithelial mesenchymal transition (EMT) may be a critical facto...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer
Autors principals: Guo, Cao, Ma, Junli, Deng, Ganlu, Qu, Yanlin, Yin, Ling, Li, Yiyi, Han, Ying, Cai, Changjing, Shen, Hong, Zeng, Shan
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5687171/
https://ncbi.nlm.nih.gov/pubmed/29151941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.20952
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars